RecruitingNCT07199738

A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA)


Sponsor

Smith & Nephew, Inc.

Enrollment

144 participants

Start Date

Sep 25, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to assess the long-term safety and performance of the LEGION Medial Stabilized insert and to generate clinical evidence to support and maintain product registration in global markets.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Cemented CoCr, a medical device called Cemented Oxinium, and others for people with inflammatory arthritis, post-traumatic arthritis, and other related conditions. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECemented CoCr

Primary TKA performed using the LEGION MS with Cemented Tibia (JII) with LEGION CR non-porous (CoCr) Femoral component

DEVICECemented Oxinium

Primary TKA performed using the LEGION MS with Cemented Tibia (JII) with LEGION CR non-porous (Ox) Femoral component

DEVICECementless

Primary TKA performed using the LEGION MS with CONCELOC Tibia with LEGION CR porous (without HA) Femoral component


Locations(4)

Newton Wellesley Hospital

Newton, Massachusetts, United States

New York University Hospital

New York, New York, United States

Medical University of South Carolina

Charleston, South Carolina, United States

University of Wisconsin

Madison, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07199738


Related Trials